MINNEAPOLIS--(BUSINESS WIRE)--Jan. 7, 2004--Orphan Medical Inc. (Nasdaq:ORPH - News) announced that it will participate in the 22nd Annual JP Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. John Bullion, Orphan Medical Chairman and CEO, is scheduled to speak at 9:00 AM PST on January 12, 2004 and is expected to discuss the Company’s current commercial products, clinical initiatives and the strategic direction of the Company. The presentation will be webcast and may be accessed at the Company’s website, www.orphan.com in the investors section. In addition, an archived version of the webcast will be available on the Company’s website.
Orphan Medical acquires, develops, and markets pharmaceuticals of high medical value for inadequately treated and uncommon diseases treated by specialist physicians. Orphan Medical intends to build a strong presence in the sleep and central nervous system (CNS) markets. Orphan Medical’s Internet Web site address is www.orphan.com
The information in this press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. A number of factors could cause actual results to differ materially from the Company’s assumptions and expectations. These are set forth in the cautionary statements included in Orphan Medical’s most recent Form 10-Q or Form 10-K filed with the Securities and Exchange Commission. (These documents can be accessed through the Orphan Medical Web site at http://www.orphan.com). All forward-looking statements are qualified by, and should be considered in conjunction with, such cautionary statements.
Contact:
Orphan Medical Inc., Minneapolis Tim McGrath, 952-513-6900 or David Folkens, 952-513-6994
Source: Orphan Medical Inc.
